You are here:

tigecycline (Tygacil)

Advice

in the absence of a submission from the holder of the marketing authorisation

tigecycline (Tygacil®) 50 mg powder for solution for infusion is not recommended for use within NHS Scotland.

Indication under review: Treatment in children from the age of eight years for the following infections:
• complicated skin and soft tissue infections, excluding diabetic foot infections
• complicated intra-abdominal infections

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: tigecycline (Tygacil)
SMC Drug ID: 1101/15
Manufacturer: Pfizer Ltd
Indication: Treatment in children from the age of eight years for the following infections: complicated skin and soft tissue infections, excluding diabetic foot infections complicated intra-abdominal infections
BNF Category:
Sub Category: 5.1 Antibacterial drugs
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 7 September 2015

Back